671
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Retrospective demographic analysis of 450 eyelid tumours

ORCID Icon, ORCID Icon & ORCID Icon
Pages 243-249 | Received 27 Dec 2022, Accepted 13 Feb 2023, Published online: 20 Feb 2023

References

  • Singh A, Damato B, Pe’er J, et al. Clinical ophthalmic oncology. Vol 1. 1st ed. 1600 John F. Kennedy Boulevard, Suite 1800, Philadelphia, PA 19103-2899, USA: Elsevier’s Health Sciences Rights Department; 2007.
  • Rosai J, Sobin LH. Histological typing of tumours of the thymus. In: International histological classification of tumours. Berlin Heidelberg: Springer-Verlag; 1999. ci.nii.ac.jp. Accessed October 21, 2020. https://ci.nii.ac.jp/naid/10014676418/
  • Sobin LH. The international histological classification of tumours. Bull World Health Organ. 1981;59(6):813–819.
  • Cook BE, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumours in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106(4):746–750.
  • Kersten RC, Ewing-Chow D, Kulwin DR, et al. Accuracy of clinical diagnosis of cutaneous eyelid lesions. Ophthalmology. 1997;104(3):479–484.
  • Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003;327(7418):794–798.
  • Singh U, Kolavali RR. Overview of eyelid tumours. In: Surgical ophthalmic oncology. Cham: Springer; 2019. 3–10.
  • Lasudry J. Prise en charge des tumeurs palpébrales: considérations générales. J Fr Ophtalmol. 2011;34(10):741–754.
  • Pe’er J. Pathology of eyelid tumours. Indian J Ophthalmol. 2016;64(3):177.
  • Zlatarova ZI, Dokova KG. Incidence of non-melanoma eyelid malignancies in Bulgaria (2000-2015). Ophthalmic Epidemiol. 2021;28(3):198–204.
  • Wang L, Shan Y, Dai X. Clinicopathological analysis of 5146 eyelid tumours and tumour-like lesions in an eye Centre in South China, 2000-2018: a retrospective cohort study. BMJ Open. 2021;11:41854.
  • Bagheri A, Tavakoli M, Kanaani A, et al. Eyelid masses: a 10-year survey from a tertiary eye hospital in Tehran. Middle East Afr J Ophthalmol. 2013;20(3):187–192.
  • Eren MA, Gündüz AK. Demographic features and histopathological diagnosis in primary eyelid tumours: results over 19 years from a tertiary center in Ankara, Turkey. Int J Ophthalmol. 2020;13(8):1287–1293.
  • Yu SS, Zhao Y, Zhao H, et al. A retrospective study of 2228 cases with eyelid tumours. Int J Ophthalmol. 2018;11(11):1835–1841.
  • Kaliki S, Bothra N, Bejjanki KM, et al. Malignant eyelid tumours in India: a study of 536 asian indian patients. Ocul Oncol Pathol. 2019;5(3):210–219.
  • Huang YY, Liang WY, Tsai CC, et al. Comparison of the clinical characteristics and outcome of benign and malignant eyelid tumours: an analysis of 4521 eyelid tumours in a tertiary medical center. Biomed Res Int. 2015;2015
  • Ul Kadir SM, Rani Mitra M, Rashid R, et al. Clinicopathological analysis and surgical outcome of eyelid malignancies: a study of 332 cases. J Skin Cancer. 2022;2022:1–9.
  • Population by statistical regions, age, place of residence and sex | National Statistical Institute. [cited 2022 Dec 15]. https://www.nsi.bg/en/content/2977/population-statistical-regions-age-place-residence-and-sex.
  • Population by districts, municipalities, place of residence and sex | National Statistical Institute of Bulgaria. [cited 2022 Dec 15]. https://www.nsi.bg/en/content/2975/population-districts-municipalities-place-residence-and-sex.